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Immunological injury mediated by immune complexes appears  to play a  major 
role in human glomerulonephritis (1). Evidence for the pathogenetic role of immune 
complexes has been derived from studies in both humans and in experimental animals 
(2).  These studies  have  focused primarily on  the role of IgG  in  nephritis because 
deposits of this immunoglobulin predominate in the affected glomeruli. In contrast, 
certain  human nephritides such as  Berger's  Disease  (3,  4)  and  Henoch-Schoenlein 
purpura (5, 6) are characterized by the predominance of IgA deposits in the affected 
glomeruli. Although this finding suggests an association between IgA and the devel- 
opment of glomerulonephritis, no direct evidence has been presented for a causal role 
of IgA immune complexes in  the pathogenesis of these nephropathies.  In  fact, an 
experimental model for the study of IgA-associated glomerulonephritis has not been 
described to date. The paucity of IgA in normal sera together with the difficulty of 
obtaining enough IgA with specificity for a single antigen, may account for the lack 
of such an experimental model. 
In this study, we describe an animal model for IgA immune complex nephropathy, 
using IgA from MOPC-315 myeloma (7) which possesses specific antigenic reactivity 
for the dinitrophenol (DNP) l hapten (8) and bovine serum albumin (BSA) conjugated 
with DNP  (DNP-BSA)  as the antigen. Immune complexes formed either in vitro or 
in  vivo with polymeric IgA, but  not  monomeric  IgA, induced  glomerulonephritic 
changes in mice. Our data also indicates that although immune complexes fix C3, the 
participation of this component of complement was not essential for the induction of 
renal injury. 
Materials and Methods 
Animals.  The inbred mice used  in  these experiments were 2-  to 3-mo-old  female BALB/c 
weighing  20-25  g.  All  mice  were  obtained  from  Charles  River Breeding  Laboratories,  Wil- 
mington, Mass. 
Antigens.  DNP-BSA was  prepared  by  the  reaction  of 2,4-dinitrobenzene  sulfonic  acid 
(Eastman Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.) with BSA (Calbi- 
ochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) at room temperature under 
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alkaline conditions as described by Eisen et al. (9). The degree of derivatization was controlled 
by the duration of the reaction; a 3-h and 22-h reaction yielded DNPj2-BSA and DNP3.~-BSA 
respectively.  The number of DNP groups per molecule of conjugated BSA was calculated from 
absorbancy at 360 nm (Molar extinction coefficient  for ~-DNP lysine: 17,530) and from the dry 
weight of protein or from estimation of protein concentration by absorption at 280 nm. 
Source of Antibody.  Murine plasmacytoma MOPC-315 (obtained through the courtesy of Dr. 
M. Potter, National Institutes of Health, Bethesda, Md.) was maintained in .serial transplants 
by subcutaneous passage  in female BALB/c mice.  Ascites  were collected by paracentesis of 
mice which had been inoculated i.p. with 5  ×  10  '~ viable tumor cells 2-3 wk earlier. Pooled 
ascites were allowed to stand for 48 h at 4°C then centrifuged at  12,000 g to remove insoluble 
residues.  Clarified ascitic fluid was stored at -20°C. The anti-DNP content of the ascitic fluid 
was determined by the quantitative precipitin reaction described by Farah et al. (10). 
Purification of lgA Anti-DNP.  Pooled  MOPC-315 ascitic fluid was  dialyzed against Tris- 
saline buffer (0.01 M Tris-0.15 M  NaCI, pH 7.4) at 4°C overnight and applied to a  DNP-L- 
lysine-Sepharose (Sepharose,  Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, 
N. J.) immunoabsorbent column prepared by the method of Rockey et al.  (11). The MOPC- 
315 protein specifically bound to the immunoabsorbent  column. Bound antibody was recovered 
by elution with  10 mM 2,4-n-E-DNP-L-lysine (Sigma Chemical Co.,  St.  Louis, Mo.)  in saline. 
The protein containing eluates were pooled, dialyzed repeatedly against Tris-saline buffer at 
4°C for 3 d, and then concentrated in an Amicon uhrafihration unit (Amicon Corp., Scientific 
Sys.  Div., Lexington, Mass.)  equipped with  UM-10 a  Diaflo membrane. The concentrated 
eluates contained only IgA as determined by immunoelectrophoresis with rabbit anti-whole 
mouse serum and anti-mouse IgA (Meloy Laboratories, Inc., Springfield, Va.). Purified IgA 
concentration was  determined from  absorbance at  280  nm using an extinction coefficient 
(E]~/'~) ~  1.44 and tool wt of 160,000 (12). The multimeric IgA recovered was fractionated 
into monomeric, dimeric, and higher polymeric forms by gel chromatography on 1.5 ×  100 cm 
column of Ultrogel AcA-34 (LK.B, Rockville, Md.). 
Antisera.  Specific anti-mouse IgA was prepared by injecting rabbits s.c. with I mg purified 
dimeric MOPC-315 IgA in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.). 
The animals were reinjected twice at 4-wk intervals with 2 mg of purified IgA in incomplete 
Freund's adjuvant and bled  1 wk after the last  injection. The pooled serum was tested for 
specificity  by immunoelectrophoresis against mouse serum. 
Goat antiserum specific for rabbit gamma globulins (GARG) was produced by i.m. injection 
of 5 mg rabbit gamma globulin (13) in complete Freund's adjuvant and the animal was bled 
2 wk later. The antiserum was shown to be monospecific for rabbit IgG by immunoelectropho- 
resis. 
Radioiodination.  DNP-protein conjugate (DNP33-BSA) was iodinated with tZ'~l by the chlor- 
amine-T method (14). 
Radioassay of lgA Anti-DNP.  A constant amount (4.5 #g)  of 12'~I-DNP-BSA was added  to 
twofold serial  dilutions of experimental mouse sera prepared in duplicate. Tris-saline buffer 
containing 20%  fetal  calf serum was  used as  the diluent. After incubation at  37°C for  1 h, 
rabbit anti-mouse IgA (50 p.I) was added and the tubes were held at 4°C for 2 h. To enhance 
precipitation, GARG (75/d) was added in exce~ and allowed to incubate for an additional 4 
h. The pellets obtained by centrifugation at 12,000 g for 20 rain at 4°C were washed twice with 
cold phosphate-buffered saline (PBS,  pH  7.2) and counted in an automatic gamma counter 
(Packard Instrument Co., Inc., Downers Grove, Ill.). Control tubes containing  only Iz~I-DNP:~:r 
BSA with rabbit anti-mouse IgA and GARG were used to determine nonspecific precipitation. 
The [gG content of experimental sera was  evaluated from  a  standard curve obtained with 
pooled MOPC-315 reference serum. The concentration of anti-DNP immunoglobulins  in the 
reference serum was determined by the quantitative precipitin curve described by Farah et al. 
(10) and a  modified Farr assay  (15) using tritium-labeled 2,4-n-~-DNP-L-lysine.  Dilutions of 
experimental sera yielding values within the linear range of the standard curve (30  70'7,  ) were 
used to calculate the IgA concentration. 
Measurement of Hematurm.  Mice were induced to urinate by stroking the lower part of their 
dorsa. The presence of an abnormal number of erythrocytes in urine of mice was detected with 
an orthotolidine reagent strip (Hemastix; Ames Co., Elkhart, Ind.). The estimation of hematuria 
as small, moderate, or large was based on the instructions accompanying the reagent strips. A.  RIFAI,  P.  SMAI,L, Jr.,  P.  TEAGUE,  AND  E.  AYOUB  1163 
Immunofluorescence Study.  Mouse  renal  tissue was  snap-frozen  in  n-hexane, and  cut  with  a 
cryostat into 4-#m sections. The sections were air dried, fixed in acetone for 10 rain at 22°C and 
washed  twice  with  PBS  and  fluorescein-labeled  antiserum  was  applied.  Antisera  used  were 
rabbit anti-mouse IgA, IgM, IgG (Meloy Laboratories, Inc.), rabbit anti-mouse C3 (courtesy of 
Dr. A. Gabrielsen, New York State Health Department, Albany, N. Y.) and rabbit anti-mouse 
fibrin (N. L. Cappel Laboratories Inc., Cochranville, Pa.). Slides were incubated for 30 min at 
37°C  in  a  humid  chamber, washed  three times with  PBS  and counterstained  for  20 s  with 
Eriochrome  Black  (Difco  Laboratories)  diluted  with  PBS  (1:50).  After  washing  twice,  the 
sections were mounted with PBS-buffered glycerol.  Examination was made by Leitz Ortholux 
microscope (E. Leitz, Inc., Rockleigh, N.J.) equipped with Ploem-type vertical illuminator and 
a  xenon  150-W  light  source.  Filters used  were:  primary  K  480,  interference Kp  500,  and  a 
secondary K  510-nm filter. 
The indirect immunofluorescent technique was used for detecting deposition of antigen with 
the  use  of rabbit  anti-BSA  or  anti-DNP  (courtesy  of Dr.  W.  Cllem,  University  of  Florida, 
Gainesville, Fla.) and fluoreseein-labeled GARG (N. L. Cappel  Laboratories, Inc.). 
Histologic Examination.  A  portion of each renal specimen was fixed in Vande Grift's solution 
for 8  h  and kept  in 80% ethanol until processed.  Tissues were paraffin embedded,  sectioned, 
and stained with periodic aeid-Schiff reagent (PAS). 
Complement Depletion  of Mice.  Decomplementation  of  mice  was  carried  out  by  the  i.p. 
injection of 10 U  of cobra venom factor (Cordis Laboratories Inc., Miami, Fla.) as described by 
Cochrane et al. (16). 
Results 
Effect of Preformed lgA Immune Complexes.  Varying amounts of DNP.~-BSA  (0.25- 
3.00 rag) were added to a constant amount of MOPC-315 ascitic fluid containing  1.7 
mg of anti-DNP  IgA. The  antigen-antibody  precipitates  were  allowed  to  stand  at 
22°C  for  10-15  min  before  injection.  The  precipitates  were  kept  in  homogeneous 
suspension  by aspiration  and  ejection  using  a  tuberculin  syringe  with  a  27-gauge 
needle.  The  immune  complexes  formed  at  different  antigen-antibody  ratios  were 
adjusted to a  vol of 0.5 ml with PBS and injected i.v. into groups of four mice each. 
Controls received either antigen  or antibody alone, The  results  are summarized  in 
Table  I.  11  of the  24  mice  receiving  the  immune complexes developed  hematuria 
which  was  detectable  2  h  after  injection  and  lasted  4-6  h,  Immune  complexes 
prepared between three- and sevenfold antigen excess were most effective in producing 
hematuria. 
TABLE  1 
Induction of Hematuria in Normal BALB/c Mice Given Preformed DNPa.rBSA-IgA Complexes Prepared 
with MOPC-315 Ascitic Fluid 
Antigen  Antibody  Equivalence 
ratio* 
Number of mice with hematuria 
Negative  Small  Moderate  Large 
rag  mg 
0.25  1.70  0.8  2  2  --  -- 
0.50  1.70  1.6  4  --  --  -- 
1.00  1.70  3.2  I  1  --  2 
1.50  1.70  4.7  2  --  --  2 
2.00  1.70  6.3  0  --  2  2 
3.00  1.70  9.5  4  --  --  -- 
2.00  --  --  4  --  --  -- 
--  1.70  --  4  --  --  -- 
* Multiple of antigen concentration at equivalence as determined by precipilin curve, 1164  EXPERIMENTAL  lgA NEPHROPATtlY 
TABLE II 
Induction of Hematuria and Renal Deposition of lgA Immune Complexes Following Injection of DNP,e- 
BSA-IgA Complexes Prepared In  Vitro in Normal BALB/c Mice 
Antigen  Antibody 
Number of mice with hematuria  Immunofluorescence* 
Negative  Small  Moderate  IgA  C3 
mg  mg 
2.0  4.0  l  --  2  3+  2+ 
2.0  3.0  --  4  --  3+  2+ 
2.0  1.5  4  --  --  3+  2+ 
2.0  0.5  4  --  --  2+  1  + 
2.0  --  4  --  --  0  0 
--  3.0  4  --  --  0  0 
* Immunofluorescence was graded on a scale of 0-3 +. 
Preformed immune complexes prepared with the lower substitution antigen, DNPt2- 
BSA and varying amounts of purified IgA were examined for their potential to induce 
hematuria  or to localize  in  the  kidneys  (Table  II).  Hematuria  was induced  only in 
mice that received complexes preformed with the higher amounts of antibody (3 or 4 
rag).  However,  immune  complexes  were  detected  by  immunofluorescence  in  the 
glomeruli of all animals receiving the immune complexes, regardless of the amount of 
antibody.  No  hematuria  or giomerular  localization  of IgA occurred  in  the  control 
animals. 
The mice that  received immune complexes prepared  with DNP12-BSA were killed 
36 h  after injection.  Histological examination using PAS staining of the renal  tissues 
of experimental  animals  revealed  morphological  changes  that  were  similar  in  all 
animals,  even  in  those that  manifested  no hematuria.  These  morphological changes 
consisted of widening of the mesangial area in  1-2~. of the glomeruli and prominent 
increase  in  intraluminal  PAS-positive material  in  ~15'~  of the  glomeruli  (Fig.  I A). 
Increase in mesangial  cells or neutrophilic  infiltration  were seldom seen.  In general, 
the light microscopy of these renal biopsies exhibited only mild histological alterations 
in  the  affected  glomeruli.  Sections  from  control  animals  that  received  antigen  or 
antibody alone (Fig.  1 B)  were similar to those of normal mice. 
Immunofluorescent microscopy demonstrated  localization of IgA in the area of the 
glomerular  mesangium  and  capillary  lumen  (Fig.  I C)  of all  glomeruli.  Staining  for 
C3 showed a  similar distribution  but  with a  lesser intensity.  In contrast  to the focal 
changes seen with PAS staining, the glomerular immunofluorescent  pattern consisted 
of generalized-diffuse granular deposits. 
Immunofluorescent  staining  of specimens  from control  mice  that  received  either 
IgA or antigen  alone,  with  anti-mouse  IgA was  negative,  lgG  was absent  from the 
glomeruli  of either  experimental  or  control  mice.  Staining  with  anti-mouse  IgM 
resulted  in  reactions  of varying of intensity  (between  trace and  2+)  in both experi- 
mental  and  in  normal  mice.  Minimal  staining  for C3,  between  negative  and  trace, 
mainly in a  peritubular  pattern,  was observed in the control group. 
Effect of IgA Immune Complexes  Formed In  Vivo.  In an attempt  to determine whether 
the  mode of formation of IgA immune complexes would  influence  their capacity to 
induce  renal  injury,  complexes  were  formed  in  vivo  by  two  methods.  The  first 
consisted  of injecting i.v.  1 or 2 mg of DNP~2-BSA into two groups of mice bearing A.  RIFAI, P.  SMALL, Jr.,  P. TEAGUE, AND E.  AYOUB  1165 
Fro.  1.  (A) Photomicrograph of a glomerulus from a mouse given one injection of DNPI2-BSA- 
IgA complexes, 2 mg  DNP1z-BSA and  3  mg  lgA, prepared in  vitro, and  killed after  36  h. 
Hypertrophy of mesangial area with PAS-positive deposits. ×  450. (B)  Photomicrograph of a 
glomerulus from a control mouse, that received 2 mg DNP~-BSA, stained with PAS. ×  4~. (C) 
Fluorescent photomicrograph  of glomeruli from  a mouse that was injected with preformed DNPI2- 
BSA-IgA complexes (2 mg DNPI2-BSA and  3 mg IgA). Kidney stained with anti-mouse lgA. 
Generalized-diffuse deposition of IgA. ×  275. 
MOPC-315  myeloma. The first group received  1 mg and the second group 2  mg of 
DNPI2-BSA. The level of circulating IgA anti-DNP in the sera of these animals, which 
fluctuated  from  day  to  day,  was  determined  by  radioimmunoassay  immediately 
before the administration of antigen.  Each animal was given an initial  (0 h)  dose of 
antigen followed by a similar dose at 60, 84, and  132 h thereafter. Mice were killed  12 
h  after the fourth dose of antigen. 
Histologic changes detected in these mice were variable. Animals with high levels 
of circulating  IgA that  received 2  mg of antigen  exhibited  a  mild  endothelial  and 
mesangial proliferative response with some neutrophilie  infiltration. The glomerular 
basement membrane was usually intact.  Mice with low levels of IgA that  received  1 
mg of antigen  were mildly affected.  Mesangial  proliferative response in  these  mice 
was focal and minimal. The characteristic abnormality detected in all these mice was 
the presence of giomerular PAS-positive deposits. Examination of 100-200 giomeruli 
from each  mouse revealed a  linear relationship  with  a  high degree of correlation  (r 
ffi 0.90;  P <  0.0001)  between the percentage of glomeruli with PAS-positive deposits 
and the level of circulating IgA in tumor-bearing mice that received  1  mg of antigen. 
Animals that received 2 mg of antigen also manifested a linear relationship (r =  0.98; 
P  ffi 0.02) with a higher percentage of glomerular involvement (Fig. 2). However, the 
intraglomerular distribution of these deposits was variable. Animals with high levels 
of circulating IgA had  a  diffuse pattern,  with  heavy mesangial and  capillary  PAS- 
positive deposits, whereas mice with low serum IgA levels manifested only segmental 
deposits. 
The immunofluorescent  pattern  was essentially  identical  in  all cases.  Despite the 
fact that  <40% of the glomeruli contained  PAS-staining  material, all  the  glomeruli 1166  EXPERIMENTAl. lgA NEPHROPATIIY 
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FiG. 2.  Effect of DNP~z-BSA-lgA complexes formed in vivo. IgA levels and the development of 
glomerular changes in tumor-bearing mice that were given 1 (0) or 2 (1:]) mg DNPvz-BSA at 0-, 
60-, 84-, and 132-h intervals. Mice were sacrificed 12 h after the last injection. 
contained  IgA deposits as determined by immunofluorescent staining.  The intraglo- 
merular pattern was diffuse with mesangial and intraluminal deposits (Fig. 3A).  No 
extraglomerular  deposits  were  observed  in  any  of the  renal  sections.  The  pattern 
resulting  from  immunohistological  staining  for  BSA  or  DNP  (Fig.  3B)  using  the 
indirect-immunofluorescent technique, was found to be similar to the pattern observed 
for IgA. Staining for C3 revealed a  diffuse intraglomerular pattern  (Fig. 3C), which 
was present  in  all glomeruli, similar to IgA immune deposition.  It should  be noted 
that  none  of  the  histologic  or  immunopathologic  changes  described  above  were 
encountered  in tumor-bearing control mice, even those with levels of IgA as high as 
16 mg/ml. 
To determine the rate of deposition and disappearance of antigen-antibody com- 
plexes  in  the  kidneys,  an  alternate  approach  for  the  formation  of  IgA  immune 
complexes in vivo was used. 2-mg quantities of DNPlz-BSA were administered i.v. to 
four groups of four normal mice each. All  16 animals were injected i.v.  with 5 mg of 
lgA anti-DNP,  10-15 min after administration of the antigen. Control mice received 
either antigen or antibody alone in the same amounts. The procedure was repeated 
after 24  h  and  the different  groups were  killed  36,  48,  72,  and  96  h  after the  first 
injection  (Table  III).  Morphologic  changes  in  mice  sacrificed  at  36  h  showed  a 
generalized-diffuse  pattern  of  PAS-positive  deposits.  These  deposits  were  mainly 
intraluminal  and  mesangial  in  distribution.  This  intraglomerular  pattern  became 
more focal at 48 h. At the end of 72 h, the PAS-positive deposits became less discrete. 
All the glomeruli appeared normal at the end of 96 h. 
Immunofluorescent staining for IgA and C3 revealed the characteristic generalized- 
diffuse pattern  of immune deposits similar to those shown  in  Fig.  3.  However, this 
pattern changed with time; the immune deposits observed at 36 h  in the mesangium A.  RIFAI, P.  SMALL,  Jr.,  P.  TEAGUE, AND E.  AYOUB  1167 
FiG.  3.  (A) Fluor~ent photomicrograph of glomeruli from a tumor-bearing mouse, with 3 mg/ 
ml of circulating anti-DNP IgA,  that received three doses of I mg I)NPI~-BSA  over a 132-h period. 
The mouse was killed 12 h after the last injection. Kidney stained with rabbit anti-mouse IgA. 
Generalized diffuse deposition of host IgA. ×  27.5. (B)  Demonstrates deposits of BSA in  the 
glomeruli by indirect immunofluorescent staining. ×  275. (C) Reveals the presence of C3 deposits 
in a granular diffuse pattern. X 27.5. 
and capillary lumina became fine mesangial granules with little  fluorescence at  the 
end of 96 h. Deposits of 123 were similar to those of IgA but the 123 deposits were only 
seen after 48 h after the first  injection rather than at  36 h, as was encountered with 
IgA deposits. There was no 123 detectable by immunofluorescence at the end of 96 h. 
Results of immunofluorescent staining for fibrin in the glomeruli of mice in which 
IgA immune complexes were formed in vivo by either of the two methods described 
above, were  negative.  However, staining  for IgG deposits  yielded  different  results. 
Examination of kidneys obtained from the two experimental groups of tumor-bearing 
animals revealed the presence of IgG in large amounts, in a pattern similar to that of 
IgA, whereas no IgG staining could be detected in the renal tissue of the normal mice 
in which IgA immune complexes were formed in vivo by the injection of DNPtz-BSA 
followed by injection of IgA-anti-DNP. 
Effect  of C3  on  Localization  of lgA  Immune  Complexes.  The  role  of complement, 
especially C3,  in  renal  deposition of IgA immune complexes was evaluated  by the 
induction of these complexes in  vivo in  two groups of mice.  In one group, C3 was 
depleted  by the administration  of cobra venom factor. Animals in  the other group 
served as controls with normal complement. Immune complexes were induced by the 
i.v.  injection of 2 mg of DNP12-BSA 15 min before challenge with 4 mg of purified 
IgA through the same route. Other control mice received either antigen or antibody 
in  the same amounts.  The animals  were sacrificed  after  48 h  and  the  tissues  were 
examined  by immunofluorescent microscopy (Table IV). As noted, depletion of 123 
had  no effect  on  the  deposition  of IgA complexes  in  the  kidneys of experimental 
animals. 
Immunofluorescent examination  revealed  a  typical generalized-diffuse pattern  of 1168  EXPERIMENTAL  lgA NEPHROPATHY 
TABLE III 
Time Course of Deposition and Disappearance of DNPt~-BSA-IgA  Complexes Formed  In  Vivo in BALB/c 
Mice 
Number of  Time sac-  Antigen  Antibody  Immunofluorescence  llistologic 
mice  rificed  IgA  C3  changes* 
h  mg  rag 
4  36  2.0  5.0  3 +  0  Present 
4  48  2.0  5.0  3 +  2 +  Present 
4  72  2.0  5.0  3 +  2 +  Present 
4  96  2.0  5.0  2 +  1  +  Absent 
4  48  2.0  --  0  0  Absent 
4  48  --  5.0  0  0  Absent 
* PAS deposits or mesangial widening. 
TABLE IV 
Effect of Treatment with Cobra Venom Factor on the Glomerular Deposition of lgA-DNPte-BSA 
Complexes Formed  In  Vivo in Normal BALB/c Mice 
Number of  Treated  Antigen  Antibody  mice 
lmmunofluorescence 
lgA  C3  BSA 
rag  mg 
3  Yes  2.0  4.0  3 +  0  2 + 
3  No  2.0  4.0  3 +  2 +  2 + 
3  No  --  4.0  0  0  0 
3  No  2.0  --  0  0  0 
lgA localized in the glomeruli of both decomplemented mice  (Fig. 4A)  and  normal 
mice (illustration not shown).  However, C3 could only be detected in the kidneys of 
those mice with normal complement (Fig. 4 B) and not in those that were complement 
depleted (Fig. 4C). Control animals that received antigen or antibody alone did not 
show any IgA or C3 deposits. 
Effect  of  the  Polymerism  of  IgA  on  the  Localization  and  Clearance  of  Immune 
Complexes.  Because the IgA produced in the ascitic fluid of the myeloma is 70-80% 
polymeric and  20-30%  monomeric,  we  investigated the capacity of complexes pre- 
pared with different forms of IgA to deposit in the kidneys. Purified muhimeric IgA 
was separated into monomeric and  polymeric forms on Uhrogel AcA-34. Preformed 
monomeric  and  multimeric  IgA  immune  complexes  were  prepared  in  vitro  with 
DNPt2-BSA.  The  immune  complexes were  administered i.v. at  0  and  24  h  to  mice 
that  were  killed  48  h  after  the  first  injection.  Immune  complexes  prepared  with 
monomeric IgA failed to deposit in the kidneys of these mice (Table V). In contrast, 
the injection of immune  complexes prepared with a  similar concentration  of multi- 
meric IgA and yielding the same antigen-to-antibody mass ratio resulted in glomerular 
deposition of the immune complexes. 
The  glomerular  deposition  of immune  complexes  formed  in  vivo  with  different 
forms of purified IgA was also examined. Immune complexes were formed in vivo by 
administering 2  mg of DNPt2-BSA  to normal  mice that  were  challenged later with A.  RIFAI,  P.  SMALL, Jr.,  P.  TEAGUE, AND  E.  AYOUB  1169 
FIG. 4.  (A) Fluorescent  photomicrograph showing IgA deposits  in glomerulus of a complement- 
depleted animal in which DNPI2-BSA-lgA  complexes were  formed in vivo.  (B) Deposits  of C3 in 
glomeruli of complement nondepleted mouse.  (C) Absence of 123 deposits  in glomerulus of comple- 
ment-depleted mouse.  ×  275. 
TABLE  g 
Glomerular Deposition in Kidneys of Normal Mice of lmmune Complexes Formed In  Vitro or In  Vivo with 
Multimeric or Monomeric lgA and DNPtz-BSA 
Preparation of immune complexes 
Num-  Immunofluores- 
Anti-  Anti-  cence  ber of  lgA form 
mice  body  gen 
lgA  C3 
Complexes preformed in vitro 
Complexes formed in vivo:l: 
mg  rag 
3  Monomeric  1.15  0.5  0  0 
3  Monomeric  1.15  1.0  0  0 
3  Monomeric  1.1 $  2.0  0  0 
3  Multimeric*  1.0  2.0  3 +  2 + 
3  Monomeric  2.0  2.0  0  0 
3  Polymeric  4.0  2.0  3 +  2 + 
3  Multimeric*  5.0  2.0  3 +  2 + 
* Muhimeric is a mixture of monomeric and polymeric. 
:I: Mice injected with DNPI2-BSA followed in  10 rain  by injection of lgA. 
either muhimeric  (a mixture of polymeric and monomeric), polymeric, or monomeric 
IgA. This procedure  was repeated  at  24 h  and  renal  tissues were obtained  at  the end 
of 48 h. Immunofluorescence microscopy demonstrated  the localization of IgA only in 
the kidneys of mice that  received muhimeric  or polymeric IgA (Table V), but  not  in 
animals that  received monomeric  IgA. Glomeruli containing multimeric or pblymeric 
IgA immune  complexes  showed  deposits  of C3  in  a  distribution  identical  to  that  of 
IgA. 1170  EXPERIMENTAL IgA NEPIIROPATllY 
Discussion 
To establish an animal model for IgA nephritis, we utilized a mouse myeloma lgA 
with anti-DNP specificity (8). Immune complexes of DNP-BSA and IgA were formed 
both in vitro and in vivo. The capacity of these complexes to produce renal disease 
was first established by showing that the IgA immune complexes induced hematuria, 
and that a certain minimal level of antigen and antibody were required. 
IgA  immune  complexes  formed  in  vitro  or  in  vivo  produced  histological  and 
immunopathological  renal changes.  The morphological changes  consisted of PAS- 
positive deposits in the capillary loops and mesangium accompanied in some cases by 
a  mild  proliferative cellular  response  in  the  mesangial  area.  These changes  were 
classified as mild focal glomerulonephritis. In contrast, immunohistoiogical staining 
invariably showed dense, granular IgA deposits in a generalized-diffuse pattern. The 
differences  in  the  degree  of histological  changes  encountered  between  PAS  and 
immunohistological staining  in  this experimental model  has also been observed in 
human  IgA  nephropathy  (4,  17). In  the  latter,  morphological changes  include  an 
increase in mesangiai matrix and the presence of PAS-positive deposits in some of the 
glomeruli.  In  most  of the  reported  cases,  the  changes  are  characterized  as  focal 
glomerulonephritis but  are  mild  and  not  distinctive.  However, immunofluorescent 
staining shows granular deposits of IgA in all giomeruli. These deposits are localized 
mainly  in  the  mesangiurn  and  capillary loops and  are accompanied sometimes by 
deposits of C3 and IgG. 
The amount of antibody and antigen in circulation, but not the antigen-antibody 
ratio,  appears  to  be  critical  in  the  production  of experimental  IgA  nephropathy. 
Tumor-bearing mice making high amounts of antibody showed a  higher percentage 
of glornerular involvement. The concentration of antigen also appears to be a factor 
related  to  the  development of nephritis.  Experimental  IgA  nephropathy  occurs in 
antibody excess as seen in some of the tumor-bearing mice that had high levels of IgA 
anti-DNP as well as in far antigen excess. This suggests that the ratio of the immune 
reactants  in  this system is  not  as critical  as the amount  of IgA. To localize in  the 
kidneys and  induce nephritis  in  the mouse,  IgG immune complexes need to be in 
moderate  antigen  excess  at  a  mass  ratio  of antigen  to  antibody  of ~0.3  (18).  In 
contrast, IgA immune complexes were nephritogenic at  14 times this ratio. 
Proof that  a  disease  is  a  result  of deposition  of  immune  complexes  requires 
demonstrating that  the immunoglobulin in the giomeruli represents antibody com- 
bined with antigen.  Although  this remains enigmatic for human  IgA nephropathy, 
because no antigen has been defined, it has been accomplished in this experimental 
model where we showed that the specific antigen, DNP-BSA, is deposited along with 
IgA. Persistence of these complexes in the renal tissue may determine the extent of the 
inflammatory reaction. Rapid catabolism of these deposits is usually accompanied by 
the disappearance of C3 and rapid recovery without histologic damage. On the other 
hand,  persistence of these complexes may trigger an  IgG antibody response which 
upon reaction with the deposited IgA complexes may produce further histopatholog- 
ical changes. Support for this hypothesis comes from our observation that the tumor- 
bearing mice which  received DNPI2-BSA over a  period of 6  d  had deposits of IgG 
along with the IgA deposits in their glomeruli. Such a  mechanism may explain the 
simultaneous presence of IgA and IgG in renal biopsies of some patients with Berger's 
Disease and Henoch-Schoenlein purpura. 
The presence of C3 in glomerular lesions has been reported in most cases of human A,  RIFAI,  P.  SMALL, Jr.,  P.  TEAGUE,  AND  E.  AYOUB  1171 
IgA nephropathy (19). In these reports,  activation of complement has been suggested 
to occur through the alternate pathway because  properdin has been detected along 
with C3 and in the absence of C4. Although the role of complement in IgA-associated 
human nephropathy is still speculative, the present findings suggest that in the mouse 
model ofIgA nephropathy, complement is not essential for the induction ofglomerular 
disease.  This conclusion is based on two findings: mice that  received  antigen first 
followed  by  IgA  shortly  thereafter  failed  to  show  complement  deposits  in  their 
glomeruli when sacrificed  12 h after the second injection. This occurred despite the 
fact that these glomeruli exhibited characteristic histologic changes of nephritis and 
contained IgA deposits  at that time. Secondly, animals that were decomplemented 
with cobra venom factor showed no complement deposition but showed glomerular 
IgA deposits  comparable to normal animals that received the same type of immune 
complexes. 
Konig and  his  co-workers  (20) reported  that  DNP  antigens, dinitrophenylated- 
human serum albumin (DNP-HSA), activate (::3 in vitro via the alternate pathway. 
This activation depends on the degree of DNP-substitution, with antigens having 32 
or more DNP residues  effecting complement activation, whereas  antigens with <19 
DNP residues  producing little or no complement activation at concentrations up to 
10 mg DNP-HSA/ml. This observation raises the possibility  that the finding of C3 
deposits  in association  with immune-complex deposits  in the glomeruli of the experi- 
mental animals in our study may be secondary to the polyanionic effect  of DNP 
antigens. This appears to be unlikely because  controls receiving either high- or low- 
substituted antigen alone showed no complement deposition and because complement 
deposition with immune complexes  occurred to the same extent in the glomeruli of 
mice that received either IgA immune complexes formed with low-substituted antigen 
(DNP~-BSA)  as well as high-substituted antigen (DNP.~-BSA) or in mice that had 
immune complexes  induced in vivo with these antigens. 
The muhimeric IgA used in this study consisted of 70-80% polymeric and 20-30% 
monomeric IgA. It was important therefore, to determine which of the two fractions 
was responsible  for the observed  pathogenetic effect. The failure of monomeric IgA 
immune  complexes  prepared  in  vitro  or  induced  in  vivo  to  localize  in  kidneys 
represents  another peculiarity of the IgA system that differentiates it from IgG. In the 
IgG system nonprecipitating antibody in preformed immune complexes  can induce 
nephritis  (21). In  contrast  to  monomeric  IgA,  purified  polymeric  IgA  immune 
complexes were capable of renal deposition. The deposition pattern of polymeric IgA 
immune complexes was similar to the one observed with the muhimeric IgA, suggest- 
ing that the polymeric form of IgA is essential  for nephritogenicity. 
The recognized  forms of human IgA nephropathy, Berger's  disease and Henoch- 
Schoenlein purpura, usually follow upper respiratory infections (22, 23). This associ- 
ation suggests that a polymeric IgA response resulting in the formation of circulating 
IgA immune complexes with the infecting agent may play a role in the pathogenesis 
of these  diseases  (24). The observation that polymeric IgA is necessary  for immune 
deposition raises the possibility of the involvement of  secretory IgA in the pathogenesis 
of some of the human nephropathies. 
Summary 
An animal model for IgA immune complex nephritis was developed. IgA immune 
complexes  formed  in  vitro  with  an  IgA  anti-dinitrophenyl  (DNP)  derived  from 1172  EXPERIMENTAL IgA NEPHROPATHY 
MOPC-315  plasmacytoma,  and  dinitrophenylated  bovine  serum  albumin  (DNP- 
BSA)  produced  mild  focal  glomerulonephritis  in  mice.  Similar,  but  more  severe 
pathological changes were produced with complexes formed in vivo either in normal 
mice or MOPC-315 tumor-bearing mice. In contrast to the focal nature of the PAS- 
positive glomerular lesions  observed by light microscopy, immunofluorescent exami- 
nation revealed IgA deposits in all glomeruli. This discrepancy between immunoflu- 
orescent  and  histopathologic  findings  as  well  as  the  distribution  of the  immune 
complexes within the affected glomeruli, are some of the features which bear resem- 
blance between this experimental model and human IgA nephropathy. 
Fixation of complement by DNP-BSA-IgA immune complexes, formed in vitro or 
in  vivo, was  shown  to  occur in  the  glorrieruli  of mice  with  IgA immune  complex 
nephropathy.  The  pattern  of C3  glomerular  deposits  was  similar  to  that  of IgA. 
However, complement proved to be nonessential for complex deposition. This conclu- 
sion  is  based  on  the observation that  decomplemented  mice,  although showing no 
deposition  of  C3  in  their  glomerulus,  developed  glomerular  immunohistologicai 
changes  similar  to  those  observed  in  experimental  mice  that  were  not  decomple- 
mented. 
Polymeric IgA was observed to be critical  for renal  deposition  of complexes and 
induction  of nephritic  histological  changes.  In  contrast,  monomeric  IgA  immune 
complexes failed  to  produce glomerular deposits.  This  finding raises  the  possibility 
that secretory IgA, which is predominantly polymeric, may play a role in human IgA- 
associated glomerulonephritis. 
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